Researchers at the University of Copenhagen and Technical University of Denmark are studying the use of marine bacteria to fight against Staphylococci, according to a Medical News Today report.
The researchers are examining the antivirulence effect marine bacteria have on staph, antivirulence meaning a compound "disarms" the infectious bacteria instead of killing them.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The marine bacteria compound Solonamid B has proved particularly effective in antivirulence therapy against staph bacteria, preventing the staph from producing the toxins that break down blood cells, according to the report. Researchers said only a fifth of the normal amount of white blood cells die when Solonamid B is added to the harmful bacteria.
Further research is needed to determine if the antivirulence compounds are also effective in animals and human beings, says the report.
More Articles on HAIs:
3 Trends in Electronic HAI Surveillance
Advocate Lutheran General CRE Outbreak Largest in U.S.
6 Public Health Statistics on Infectious Diseases in Hospitals